• Utilize ultrasound to identify embryonic and fetal abnormalities associated with maternal diabetes;
• Understand the difference between abnormalities associated with maternal diabetes that develop during the embryonic period versus the fetal period; and
• Improve patient outcome by understanding the importance of optimizing glycemic control before and during pregnancy related to diabetic embryopathy and fetopathy.

Release Date: 10/13/2020